495 related articles for article (PubMed ID: 31850592)
1. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
[TBL] [Abstract][Full Text] [Related]
2. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.
Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA
Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443
[TBL] [Abstract][Full Text] [Related]
3. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
[TBL] [Abstract][Full Text] [Related]
4. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
[TBL] [Abstract][Full Text] [Related]
7. From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.
Rubboli A; Barbaresi E; Rocca B
Cardiovasc Drugs Ther; 2020 Feb; 34(1):143-144. PubMed ID: 31792664
[No Abstract] [Full Text] [Related]
8. Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines.
Vora AN; Wang TY; Li S; Chiswell K; Hess C; Lopes RD; Rao SV; Peterson ED
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862960
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
Mishra A; Singh M; Acker WW; Kamboj S; Sporn D; Stapleton D; Kaluski E
J Cardiovasc Pharmacol; 2019 Aug; 74(2):82-90. PubMed ID: 31306367
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
11. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome.
Franchina AG; Calderone D; D'Arrigo P; Ingala S; Milluzzo RP; Greco A; Spagnolo M; Tamburino C; Capodanno D
Cardiol J; 2020; 27(1):8-15. PubMed ID: 31960945
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
[TBL] [Abstract][Full Text] [Related]
14. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.
Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T
Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting.
Lacoste JL; Hansen CL
Am J Health Syst Pharm; 2019 Sep; 76(18):1395-1402. PubMed ID: 31505555
[TBL] [Abstract][Full Text] [Related]
17. The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Triska J; Haddadin F; Madanat L; Jabri A; Daher M; Birnbaum Y; Jneid H
Cardiovasc Drugs Ther; 2024 Jun; 38(3):605-619. PubMed ID: 35829979
[TBL] [Abstract][Full Text] [Related]
18. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
[TBL] [Abstract][Full Text] [Related]
19. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
[TBL] [Abstract][Full Text] [Related]
20. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
Saito Y; Kobayashi Y
J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]